Image
04.01.2022
Hormonal condition MACS linked to type 2 diabetes
Research we've funded has shown for the first time the scale and impact of MACS, a hormonal condition, th...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more